Company / Working Capital
MEDICINOVA INC Working Capital History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$27.2M
FY2025
5-year range
$27.2M / $69.2M
FY2021-FY2025
Trend
-28.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has declined for 4 consecutive years, from $69M in FY2021 to $27M in FY2025.
Based on SEC 10-K filings.
$27M in FY2025 with a 3-year CAGR of -21.3%.
Declined from $48M to $27M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -21.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- MEDICINOVA INC's working capital has declined for 4 consecutive years.
- 3-year CAGR of -21.3%, indicating a declining trend.
- In FY2025, working capital decreased 28.7% year-over-year.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.2M | -28.7% |
| FY2024 | $38.1M | -20.4% |
| FY2023 | $47.9M | -14.2% |
| FY2022 | $55.8M | -19.3% |
| FY2021 | $69.2M | +556.4% |
| FY2014 | $10.5M | -24.3% |
| FY2013 | $13.9M | +311.4% |
| FY2012 | $3.4M | -71.8% |
| FY2011 | $12.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026